The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients.

Zuzana Ozaniak StrizovaMartin SnajdaufDmitry StakheevPavla TaborskaJiri VachtenheimJan BiskupRobert LischkeJirina BartunkovaDaniel Smrz

Published in: Journal of cancer research and clinical oncology (2020)

The novel association of the disease state with tumoral and paratumoral immune cell signatures suggests new possibilities for personalized immunotherapy for EC patients.

Keyphrases

end stage renal disease
ejection fraction
healthcare
peritoneal dialysis
primary care
risk assessment